Transient ischemic attack - Revision history

Danbot: Move calculators to own section with header (visible in TOC), expanded, before External Links

2026-03-21T15:07:08Z

Move calculators to own section with header (visible in TOC), expanded, before External Links

← Older revision		Revision as of 15:07, 21 March 2026
Line 142:		Line 142:
	***Transient, fluctuating or persistent language/speech disturbance		***Transient, fluctuating or persistent language/speech disturbance
	***And/or fluctuating or persistent symptoms without motor weakness or language/speech disturbance		***And/or fluctuating or persistent symptoms without motor weakness or language/speech disturbance

			== Calculators ==
			{{ABCD2_Calculator}}

	==External Links==		==External Links==
Line 153:		Line 156:
	==References==		==References==
	<references/>		<references/>

	~~<div class="mw-collapsible mw-collapsed" style="border:1px solid #aaa; padding:5px; margin-top:10px;">~~
	~~<div style="font-weight:bold;">📊 ABCD2 Score for TIA Calculator [show]</div>~~
	~~<div class="mw-collapsible-content">~~
	~~{{ABCD2_Calculator}}~~
	~~</div>~~
	~~</div>~~
	[[Category:Neurology]]		[[Category:Neurology]]

Danbot: Add ABCD2 Score for TIA calculator (collapsible)

2026-03-21T13:42:59Z

Add ABCD2 Score for TIA calculator (collapsible)

← Older revision		Revision as of 13:42, 21 March 2026
Line 153:		Line 153:
	==References==		==References==
	<references/>		<references/>

			<div class="mw-collapsible mw-collapsed" style="border:1px solid #aaa; padding:5px; margin-top:10px;">
			<div style="font-weight:bold;">📊 ABCD2 Score for TIA Calculator [show]</div>
			<div class="mw-collapsible-content">
			{{ABCD2_Calculator}}
			</div>
			</div>
	[[Category:Neurology]]		[[Category:Neurology]]

Danbot: Add MedicationDose entries for aspirin, clopidogrel

2026-03-20T21:08:12Z

Add MedicationDose entries for aspirin, clopidogrel

@@ Line 24: / Line 24: @@
 **Load with [[Aspirin]] 325 mg chewed, followed by ASA 81 mg PO daily
 **Load with [[Clopidogrel]] 300 mg PO followed by 75 mg daily for 3 weeks only
 ==Disposition==

Josgood: /* Canadian TIA Score */

2022-05-18T02:43:03Z

Canadian TIA Score

← Older revision		Revision as of 02:43, 18 May 2022
Line 40:		Line 40:
	'''Item Scoring'''		'''Item Scoring'''
	*Clinical Findings:		*Clinical Findings:
	**1. First TIA (~~inn~~ lifetime) (2 pt)		**1. First TIA (in lifetime) (2 pt)
	**2. Symptoms ≥10 minutes (2 pt)		**2. Symptoms ≥10 minutes (2 pt)
	**3. Past history of carotid stenosis (2 pt)		**3. Past history of carotid stenosis (2 pt)

Josgood: /* ACEP GuidelinesACEP Clinical Policy: Suspected Transient Ischemic Attack full text */

2022-05-17T20:16:05Z

ACEP GuidelinesACEP Clinical Policy: Suspected Transient Ischemic Attack full text

← Older revision		Revision as of 20:16, 17 May 2022
Line 26:		Line 26:

	==Disposition==		==Disposition==
	===ACEP Guidelines<ref name="ACEP">~~ACEP Clinical Policy: Suspected Transient Ischemic Attack [https://www.acep.org/patient-care/clinical-policies/suspected-transient-ischemic-attack/ full text]~~</ref>===		===ACEP Guidelines<ref name="ACEP"></ref>===
	*Level B: In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, age, blood pressure, clinical features, duration of TIA and presence of diabetes [ABCD2] score) to identify TIA patients who can be safely discharged from the ED.		*Level B: In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, age, blood pressure, clinical features, duration of TIA and presence of diabetes [ABCD2] score) to identify TIA patients who can be safely discharged from the ED.
	**In contrast to the 2009 AHA/ASA recommendations that were based on limited research, the ABCD2 does not sufficiently identify the short-term risk for stroke to use alone as a risk-stratification instrument.		**In contrast to the 2009 AHA/ASA recommendations that were based on limited research, the ABCD2 does not sufficiently identify the short-term risk for stroke to use alone as a risk-stratification instrument.

Josgood at 20:07, 17 May 2022

2022-05-17T20:07:36Z

← Older revision		Revision as of 20:07, 17 May 2022
Line 26:		Line 26:

	==Disposition==		==Disposition==
	===ACEP Guidelines<ref name="ACEP">ACEP Clinical Policy: Suspected Transient Ischemic Attack [~~https://~~https://www.acep.org/patient-care/clinical-policies/suspected-transient-ischemic-attack/ full text]</ref>===		===ACEP Guidelines<ref name="ACEP">ACEP Clinical Policy: Suspected Transient Ischemic Attack [https://www.acep.org/patient-care/clinical-policies/suspected-transient-ischemic-attack/ full text]</ref>===
	*Level B: In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, age, blood pressure, clinical features, duration of TIA and presence of diabetes [ABCD2] score) to identify TIA patients who can be safely discharged from the ED.		*Level B: In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, age, blood pressure, clinical features, duration of TIA and presence of diabetes [ABCD2] score) to identify TIA patients who can be safely discharged from the ED.
	**In contrast to the 2009 AHA/ASA recommendations that were based on limited research, the ABCD2 does not sufficiently identify the short-term risk for stroke to use alone as a risk-stratification instrument.		**In contrast to the 2009 AHA/ASA recommendations that were based on limited research, the ABCD2 does not sufficiently identify the short-term risk for stroke to use alone as a risk-stratification instrument.

Josgood: /* Disposition */

2022-05-17T20:01:02Z

Disposition

← Older revision		Revision as of 20:01, 17 May 2022
Line 26:		Line 26:

	==Disposition==		==Disposition==
	===ACEP Guidelines<ref name="ACEP">ACEP Clinical Policy: Suspected Transient Ischemic Attack[https://www.acep.org/~~Physician~~-~~Resources~~/~~Policies/Clinical~~-policies/~~Clinical-Policy-Suspected~~-~~Transient~~-~~Ischemic~~-~~Attack~~/ full text]</ref>===		===ACEP Guidelines<ref name="ACEP">ACEP Clinical Policy: Suspected Transient Ischemic Attack [https://https://www.acep.org/patient-care/clinical-policies/suspected-transient-ischemic-attack/ full text]</ref>===
	*Level B: In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, age, blood pressure, clinical features, duration of TIA and presence of diabetes [ABCD2] score) to identify TIA patients who can be safely discharged from the ED.		*Level B: In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, age, blood pressure, clinical features, duration of TIA and presence of diabetes [ABCD2] score) to identify TIA patients who can be safely discharged from the ED.
	**In contrast to the 2009 AHA/ASA recommendations that were based on limited research, the ABCD2 does not sufficiently identify the short-term risk for stroke to use alone as a risk-stratification instrument.		**In contrast to the 2009 AHA/ASA recommendations that were based on limited research, the ABCD2 does not sufficiently identify the short-term risk for stroke to use alone as a risk-stratification instrument.

Masoodrm: /* Management */

2021-04-28T21:16:46Z

Management

← Older revision		Revision as of 21:16, 28 April 2021
Line 20:		Line 20:
	==Management==		==Management==
	*Little acute management (given normally resolution of symptoms)		*Little acute management (given normally resolution of symptoms)
	*Consider [[~~aspirin~~]] (once hemorrhage ruled-out)		*Consider [[Aspirin]] 325 mg PO (once hemorrhage ruled-out) for low risk TIA (ABCD2 score < 4)
	*Consider dual [[antiplatelet]] therapy for high risk ~~TIAs~~<ref>Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19;379(3):215-225.</ref>		*Consider dual [[antiplatelet]] therapy for high risk TIA (ABCD2 score ≥ 4)<ref>Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19;379(3):215-225.</ref>
	**Load with [[~~ASA~~]] 325 mg chewed, followed by ASA 81 mg PO daily		**Load with [[Aspirin]] 325 mg chewed, followed by ASA 81 mg PO daily
	**Load with [[~~clopidogrel~~]] 300 mg PO followed by 75 mg daily for 3 weeks only		**Load with [[Clopidogrel]] 300 mg PO followed by 75 mg daily for 3 weeks only

	==Disposition==		==Disposition==

Streacycr: /* Prognosis */

2021-02-24T21:27:20Z

Prognosis

@@ Line 55: / Line 55: @@
 **3.Platelet count≥400×109/L (2 pt)
 **4.Glucose ≥15 mmol/L (3pt)
 ===ABCD2 Score<ref>Johnston SC, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack.Lancet. 2007; 369(9558):283-92.</ref>===

Streacycr: /* Prognosis */

2021-02-24T21:18:28Z

Prognosis

← Older revision		Revision as of 21:18, 24 February 2021
Line 36:		Line 36:
	==Prognosis==		==Prognosis==

	===Canadian TIA Score		===Canadian TIA Score===
	*The score offers better performance than ABCD2 in predicting stroke risk after TIA, particularly low risk. <ref>Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.BMJ 2021 Feb 4.</ref>~~===~~		*The score offers better performance than ABCD2 in predicting stroke risk after TIA, particularly low risk. <ref>Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.BMJ 2021 Feb 4.</ref>
	'''Item Scoring'''		'''Item Scoring'''
	*Clinical Findings:		*Clinical Findings: